Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Farmakis

Showing results (221-230 of 297) with videos related to

Pageof 30
Sort By:
European Journal of Preventive Cardiology|June 20, 2014
Efficacy and safety of functional electrical stimulation of lower limb muscles in elderly patients with chronic heart failure: A pilot studyJohn Parissis, Apostolos Karavidas, Dimitrios Farmakis, et al.
European Journal of Heart Failure|May 4, 2013
Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failureJohn T Parissis, Dimitrios Farmakis, Katerina Fountoulaki, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 9, 2014
Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failureIoannis Alexanian, John Parissis, Dimitrios Farmakis, et al.
European Journal of Heart Failure|March 3, 2022
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trialGerasimos Filippatos, Bertram Pitt, Rajiv Agarwal, et al.
ESC Heart Failure|August 4, 2017
Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of CardiologyPatrizio Lancellotti, Maurizio Galderisi, Erwan Donal, et al.
European Journal of Heart Failure|March 16, 2018
Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial growth factor-A in heart failure with reduced ejection fractionNikolas Magkoutis, Vassiliki Mantzaraki, Dimitrios Farmakis, et al.
European Heart Journal|December 10, 2013
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trialGerasimos Filippatos, John R Teerlink, Dimitrios Farmakis, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
Journal of Molecular and Cellular Cardiology|February 4, 2014
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolismIoanna Andreadou, Emmanuel Mikros, Konstantinos Ioannidis, et al.
European Journal of Heart Failure|June 22, 2013
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trialGerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, et al.
Pageof 30

Showing results (221-230 of 297) with videos related to

Sort By:
Pageof 30
European Journal of Preventive Cardiology|June 20, 2014
Efficacy and safety of functional electrical stimulation of lower limb muscles in elderly patients with chronic heart failure: A pilot studyJohn Parissis, Apostolos Karavidas, Dimitrios Farmakis, et al.
European Journal of Heart Failure|May 4, 2013
Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failureJohn T Parissis, Dimitrios Farmakis, Katerina Fountoulaki, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 9, 2014
Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failureIoannis Alexanian, John Parissis, Dimitrios Farmakis, et al.
European Journal of Heart Failure|March 3, 2022
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trialGerasimos Filippatos, Bertram Pitt, Rajiv Agarwal, et al.
ESC Heart Failure|August 4, 2017
Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of CardiologyPatrizio Lancellotti, Maurizio Galderisi, Erwan Donal, et al.
European Journal of Heart Failure|March 16, 2018
Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial growth factor-A in heart failure with reduced ejection fractionNikolas Magkoutis, Vassiliki Mantzaraki, Dimitrios Farmakis, et al.
European Heart Journal|December 10, 2013
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trialGerasimos Filippatos, John R Teerlink, Dimitrios Farmakis, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
Journal of Molecular and Cellular Cardiology|February 4, 2014
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolismIoanna Andreadou, Emmanuel Mikros, Konstantinos Ioannidis, et al.
European Journal of Heart Failure|June 22, 2013
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trialGerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, et al.
Pageof 30